A Study to Evaluate the Anti-pruritic Effectiveness of ASN008 in Adults With Mild to Moderate Atopic Dermatitis
Public ClinicalTrials.gov record NCT05870865. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Vehicle-Controlled, Phase 2 Trial to Evaluate the Anti-pruritic Efficacy, Safety, Tolerability, and Pharmacokinetics of ASN008 in Adults With Mild to Moderate Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this clinical trial is to evaluate ASN008 in people with itch caused by eczema. The main questions it aims to answer are: * What is the efficacy and safety of ASN008? * What is the impact of ASN008 on itch in patients with atopic dermatitis? Participants will be asked to apply topical ASN008, or matching vehicle (placebo containing no active drug), to their eczema lesions twice daily for 4 weeks. Researchers will compare 3 different doses of ASN008 and a matching vehicle group to see which group responds best.
Study identification
- NCT ID
- NCT05870865
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 144 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2, 2023
- Primary completion
- Nov 26, 2023
- Completion
- Dec 27, 2023
- Last update posted
- May 15, 2025
2023
United States locations
- U.S. sites
- 27
- U.S. states
- 18
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| TrialSpark Investigative Site 0106 | Scottsdale | Arizona | 85255 | — |
| TrialSpark Investigative Site 0118 | Hot Springs | Arkansas | 71913 | — |
| TrialSpark Investigative Site 0123 | Beverly Hills | California | 90212 | — |
| TrialSpark Investigative Site 0113 | Fremont | California | 94538 | — |
| TrialSpark Investigative Site 0101 | Los Angeles | California | 90057 | — |
| TrialSpark Investigative Site 0103 | Miami Lakes | Florida | 33014 | — |
| TrialSpark Investigative Site 0129 | Miramar | Florida | 33027 | — |
| TrialSpark Investigative Site 0131 | Clarksville | Indiana | 47129 | — |
| TrialSpark Investigative Site 0109 | Indianapolis | Indiana | 46250 | — |
| TrialSpark Investigative Site 0112 | Louisville | Kentucky | 40241 | — |
| TrialSpark Investigative Site 0108 | Baton Rouge | Louisiana | 70808 | — |
| TrialSpark Investigative Site 0124 | Monroe | Louisiana | 71201 | — |
| TrialSpark Investigative Site 0107 | Auburn Hills | Michigan | 48326 | — |
| TrialSpark Investigative Site 0102 | Saint Joseph | Missouri | 54506 | — |
| TrialSpark Investigative Site 0115 | Kew Gardens | New York | 11415 | — |
| TrialSpark Investigative Site 0119 | New York | New York | 10075 | — |
| TrialSpark Investigative Site 0105 | Wilmington | North Carolina | 28405 | — |
| TrialSpark Investigative Site 0125 | Mason | Ohio | 45040 | — |
| TrialSpark Investigative Site 0127 | Oklahoma City | Oklahoma | 73170 | — |
| TrialSpark Investigative Site 0122 | Philadelphia | Pennsylvania | 19103 | — |
| TrialSpark Investigative Site 0121 | Houston | Texas | 77056 | — |
| TrialSpark Investigative Site 0130 | Pflugerville | Texas | 78660 | — |
| TrialSpark Investigative Site 0114 | San Antonio | Texas | 78213 | — |
| TrialSpark Investigative Site 0126 | San Antonio | Texas | 78229 | — |
| TrialSpark Investigative Site 0110 | Springville | Utah | 84663 | — |
| TrialSpark Investigative Site 0117 | Richmond | Virginia | 23226 | — |
| TrialSpark Investigative Site 0128 | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05870865, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 15, 2025 · Synced Sep 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05870865 live on ClinicalTrials.gov.